Holmes Biopharma, Inc. (LMB) Misses Q2 EPS by 3c, Miss on Revenues; Offers FY17 Revenue Mid-Point Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 49.48 +1.08 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.40 | 52 Week High | $0.15 | |||
| Open | $48.88 | 52 Week Low | $0.15 | |||
| Day High | $50.39 | P/E | N/A | |||
| Day Low | $48.87 | EPS | $0.00 | |||
| Volume | 54,452 | |||||
